A potassium channel opener is a type of drug which facilitates ion transmission through potassium channels.
Some examples include:
Class | Subclasses | Activators |
---|---|---|
Calcium-activated | [citation needed]
| |
Inwardly rectifying |
|
[citation needed]
|
|
[citation needed]
| |
|
[citation needed]
| |
Tandem pore domain | [citation needed] | |
Voltage-gated |
|
XEN1101 is a novel positive allosteric modulator ("opener") of the potassium channel KCNQ2/3 (Kv7.2/7.3) currently being developed by Xenon Pharmaceuticals Inc. for the treatment of focal epilepsy.